Showing results (11-20 of 152) with videos related to
Sort By:
Pageof 16
Presse Medicale (Paris, France : 1983)|May 6, 2014
Why and how should we measure disease activity and damage in lupus?Joy Feld, David IsenbergCurrent Opinion in Pharmacology|July 15, 2004
Anti B cell therapy (rituximab) in the treatment of autoimmune diseasesHanadi Kazkaz, David IsenbergRheumatology (Oxford, England)|August 24, 2016
Kidney disease in primary anti-phospholipid antibody syndromeBorja Gracia-Tello, David IsenbergExpert Opinion on Pharmacotherapy|September 13, 2018
An evaluation of voclosporin for the treatment of lupus nephritisFang En Sin, David IsenbergFrontiers in Medicine|June 2, 2022
Differences in the Development of Adverse Infusion Reactions to Rituximab in Patients With Systemic Lupus Erythematosus, Rheumatoid Arthritis and Non-Hodgkin's Lymphoma-Enigma VariationsSergio Gilaberte Reyzabal, David IsenbergLupus|January 21, 2021
Analysis of trends and causes of death in SLE patients over a 40-years period in a cohort of patients in the United KingdomAna Lorenzo-Vizcaya, David IsenbergArthritis Research & Therapy|June 8, 2004
B cell depletion in autoimmune diseaseClaire Gorman, Maria Leandro, David IsenbergExpert Review of Clinical Immunology|November 15, 2016
Improving B-cell depletion in systemic lupus erythematosus and rheumatoid arthritisPedro Mota, Venkat Reddy, David IsenbergExpert Opinion on Pharmacotherapy|April 20, 2025
Challenges of anticoagulation in patients with systemic lupus erythematosusLuigi Zolio, Hannah Cohen, David IsenbergLancet (London, England)|August 27, 2013
Systemic lupus erythematosus and other autoimmune rheumatic diseases: challenges to treatmentGrainne Murphy, Larissa Lisnevskaia, David IsenbergPageof 16